{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:52Z","timestamp":1789771492974,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016126","name":"Beijing Hospitals Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejogrb.2022.07.009","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T12:20:13Z","timestamp":1657801213000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study"],"prefix":"10.1016","volume":"276","author":[{"given":"Zhenhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2022.07.009_b0005","unstructured":"WHO. GUIDELINES FOR THE PREVENTION, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS B INFECTION. World Health Organization. 19 March 2015. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hepatitis\/treatment-care\/treatment-hbv. Cited 15 Febuary 2021."},{"key":"10.1016\/j.ejogrb.2022.07.009_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/514610","article-title":"Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors","volume":"27","author":"Ngui","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0020","doi-asserted-by":"crossref","first-page":"1374276","DOI":"10.1155\/2020\/1374276","article-title":"Efficacy and safety of lamivudine or telbivudine in preventing mother-to-child transmission of hepatitis B virus: a real-world study","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","article-title":"Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus","volume":"61","author":"Greenup","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0030","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jvh.13156","article-title":"Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: a real-life practice","volume":"26","author":"Liu","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0035","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis b transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jcv.2012.11.019","article-title":"Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus","volume":"56","author":"Kim","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MCG.0000000000000822","article-title":"Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B","volume":"52","author":"Chang","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0050","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.3748\/wjg.v18.i45.6645","article-title":"Safety of lamivudine treatment for chronic hepatitis B in early pregnancy","volume":"18","author":"Yi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0055","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/jvh.12785","article-title":"Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up","volume":"24","author":"Shang","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0060","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1111\/jvh.12788","article-title":"Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother-to-child transmission of hepatitis B virus","volume":"24","author":"Yi","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0065","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/MEG.0000000000001662","article-title":"The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B","volume":"32","author":"Gao","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27837","article-title":"Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","article-title":"Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis","volume":"21","author":"Funk","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0085","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","author":"Han","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.14218\/JCTH.2020.00070","article-title":"2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus","volume":"8","author":"Liu","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-017-0608-7","article-title":"Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission","volume":"17","author":"Sun","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0110","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/apt.16123","article-title":"Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America","volume":"52","author":"Samadi Kochaksaraei","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/1471-0528.16217","article-title":"Chronic hepatitis B infection and the risk of gestational diabetes: a cross-sectional study","volume":"127","author":"Giles","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0120","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1111\/jvh.12066","article-title":"Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy","volume":"20","author":"Liu","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0125","doi-asserted-by":"crossref","first-page":"13631","DOI":"10.1038\/s41598-020-70644-4","article-title":"Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus","volume":"10","author":"Pan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0130","unstructured":"Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry Interim Report for 1 January 1989 through 31 July 2020. Available from: http:\/\/apregistry.com\/forms\/exec-summary.pdf. Cited 20 Febuary 2021."},{"key":"10.1016\/j.ejogrb.2022.07.009_b0135","unstructured":"National Health and Family Planning Commission. National comprehensive prevention and control program for birth defects. Available from: http:\/\/www.nhc.gov.cn\/jkfpwlz\/gzdt1ur\/201902\/ 97b46d93709a4333b90249d50e9c553c.shtml. Cited 20 February 2021."},{"key":"10.1016\/j.ejogrb.2022.07.009_b0140","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","article-title":"Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B","volume":"64","author":"Giles","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0145","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.14309\/ajg.0000000000000221","article-title":"Total alanine aminotransferase (ALT) flares in pregnant North American women with chronic hepatitis B infection: results from a prospective observational study","volume":"114","author":"Bzowej","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0150","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/ajg.2016.296","article-title":"Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jgh.13436","article-title":"Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus","volume":"32","author":"Liu","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejogrb.2022.07.009_b0160","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/liv.13594","article-title":"Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study","volume":"38","author":"Kushner","year":"2018","journal-title":"Liver Int"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522004316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522004316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:57:43Z","timestamp":1759557463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522004316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"alternative-id":["S0301211522004316"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.07.009","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}